Supriya Lifescience Opens Strong with 4.2% Gain, Outpacing Sector Performance
Supriya Lifescience, a midcap pharmaceutical company, has demonstrated notable market activity, opening with a gain and reaching a high of Rs 655.1. The stock is currently above its 5-day and 200-day moving averages, reflecting its active presence despite recent challenges over the past month.
Supriya Lifescience, a midcap player in the Pharmaceuticals & Drugs industry, has shown significant activity today, opening with a gain of 4.2%. The stock's performance has outpaced its sector by 5.16%, reflecting a strong intraday movement that saw it reach a high of Rs 655.1. In terms of technical indicators, Supriya Lifescience's stock is currently positioned above its 5-day and 200-day moving averages, although it remains below the 20-day, 50-day, and 100-day moving averages. Over the past day, the stock has increased by 3.77%, while the Sensex has risen by 2.47%. However, the stock has faced challenges over the past month, declining by 7.95% compared to the Sensex's gain of 8.33%.
The stock is classified as high beta, with an adjusted beta of 1.16, indicating that it tends to experience larger fluctuations than the broader market. This volatility can present both opportunities and risks for investors. Overall, Supriya Lifescience's current performance metrics highlight its active presence in the market today.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
